Delivery Order SPE2DR25D1053-SPE2DR26FT594
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) vaccine syringes in the amount of $1,302.58. The order was competitively awarded without a set-aside designation and is scheduled for completion by November 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support...
- The Defense Logistics Agency awarded a $12,610.60 delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine doses (0.25 mL syringes for ages 6-11) with a completion deadline of December 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,579.20 for Spikevax 2025-26 vaccine (12 years and up) in 0.5ML syringes, with a completion date of November 21, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,861.40 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) vaccine syringes (0.25ML) on October 30, 2025, with completion required by November 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will...
- The Defense Logistics Agency awarded a $2,605.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for Spikevax 2025-26 vaccine syringes (6 months to 11 years, 0.25ML) to be delivered to the company's facility in Conshohocken, Pennsylvania by September 26, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value...
- The Defense Logistics Agency awarded a $1,087.46 firm fixed price delivery order to AmerisourceBergen Drug Corp for Spikevax 2025-26 vaccine (12 years and older), 0.5 mL syringes, with an ultimate completion date of November 20, 2025. This non-set-aside competitive award was issued on October 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,302.58 to supply Spikevax 2025-26 vaccine (6M-11Y) in 0.25ML syringes, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,953.84 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25ML on September 26, 2025, with a completion date of September 29, 2025. This firm fixed price delivery order represents a pediatric vaccine supply for children ages 6 months to 11 years and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,195.01 to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) Syringe 0.25ML, a pediatric COVID-19 vaccine formulation. This firm fixed price delivery order, awarded on October 29, 2025, with an ultimate completion date of November 20, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a $1,953.87 delivery order to AmerisourceBergen Drug Corp for SPIKEVAX 2025-26 (6M-11Y) syringes at 0.25ML, with an ultimate completion date of November 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT594Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,152.65 to supply SPIKEVAX 2025-26 vaccine syringes (0.25ml for ages 6-11 years) with a completion date of November 26, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company's extensive federal contract portfolio encompasses vaccines, specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. As a primary vendor within DLA's Medical Supply Chain, AmerisourceBergen regularly fulfills delivery orders ranging from modest transactions to substantial orders, demonstrating its capability to meet diverse federal healthcare requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 11/4/25 |